Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc G Ghany

Showing results (21-30 of 182) with videos related to

Pageof 19
Sort By:
Gastroenterology Clinics of North America|October 19, 2010
Pharmacokinetics and pharmacodynamics of peginterferon and ribavirin: implications for clinical efficacy in the treatment of chronic hepatitis CMazen Noureddin, Marc G Ghany
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 19, 2006
Efforts to define the natural history of chronic hepatitis C continueMarc G Ghany, Leonard B Seeff
Gastroenterology Clinics of North America|August 25, 2004
Management of chronic hepatitis BMarc G Ghany, Edward C Doo
The Lancet. Infectious Diseases|March 26, 2013
Acute hepatitis C: to treat or not to treatNiharika R Samala, Marc G Ghany
Alimentary Pharmacology & Therapeutics|June 6, 2025
Editorial: Clinical Impact of Lipid Profile Change After DAA Treatment in CHC Patients-Authors' ReplyZahra Sarrafan-Chaharsoughi, Marc G Ghany
Annals of Internal Medicine|December 7, 2007
Evolution of therapy for chronic hepatitis B: progressing from the simple to the complexJordan J Feld, Marc G Ghany
Clinical Liver Disease|April 18, 2019
Hepatitis B virus treatment: Management of antiviral drug resistanceMichele M Tana, Marc G Ghany
The American Journal of Gastroenterology|March 20, 2023
Patients With Compensated Hepatitis B Virus-Related Cirrhosis and Low-Level Viremia: Treat or Not to Treat?Marc G Ghany, Vivek A Saraswat
The New England Journal of Medicine|May 17, 2013
Current and future therapies for hepatitis C virus infectionT Jake Liang, Marc G Ghany
Hepatology (Baltimore, Md.)|April 29, 2009
Antiviral resistance and hepatitis B therapyMarc G Ghany, Edward C Doo
Pageof 19

Showing results (21-30 of 182) with videos related to

Sort By:
Pageof 19
Gastroenterology Clinics of North America|October 19, 2010
Pharmacokinetics and pharmacodynamics of peginterferon and ribavirin: implications for clinical efficacy in the treatment of chronic hepatitis CMazen Noureddin, Marc G Ghany
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 19, 2006
Efforts to define the natural history of chronic hepatitis C continueMarc G Ghany, Leonard B Seeff
Gastroenterology Clinics of North America|August 25, 2004
Management of chronic hepatitis BMarc G Ghany, Edward C Doo
The Lancet. Infectious Diseases|March 26, 2013
Acute hepatitis C: to treat or not to treatNiharika R Samala, Marc G Ghany
Alimentary Pharmacology & Therapeutics|June 6, 2025
Editorial: Clinical Impact of Lipid Profile Change After DAA Treatment in CHC Patients-Authors' ReplyZahra Sarrafan-Chaharsoughi, Marc G Ghany
Annals of Internal Medicine|December 7, 2007
Evolution of therapy for chronic hepatitis B: progressing from the simple to the complexJordan J Feld, Marc G Ghany
Clinical Liver Disease|April 18, 2019
Hepatitis B virus treatment: Management of antiviral drug resistanceMichele M Tana, Marc G Ghany
The American Journal of Gastroenterology|March 20, 2023
Patients With Compensated Hepatitis B Virus-Related Cirrhosis and Low-Level Viremia: Treat or Not to Treat?Marc G Ghany, Vivek A Saraswat
The New England Journal of Medicine|May 17, 2013
Current and future therapies for hepatitis C virus infectionT Jake Liang, Marc G Ghany
Hepatology (Baltimore, Md.)|April 29, 2009
Antiviral resistance and hepatitis B therapyMarc G Ghany, Edward C Doo
Pageof 19